ImaginAb Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • ImaginAb's estimated annual revenue is currently $5.3M per year.(i)
  • ImaginAb's estimated revenue per employee is $155,000

Employee Data

  • ImaginAb has 34 Employees.(i)
  • ImaginAb grew their employee count by -26% last year.

ImaginAb's People

NameTitleEmail/Phone
1
FounderReveal Email/Phone
2
CEOReveal Email/Phone
3
CFOReveal Email/Phone
4
VP Business StrategyReveal Email/Phone
5
ControllerReveal Email/Phone
6
VP, OperationsReveal Email/Phone
7
VP, Global Operations | Senior Director Clinical Development | Program DirectorReveal Email/Phone
8
Director Business DevelopmentReveal Email/Phone
9
Director Research - Biologics DiscoveryReveal Email/Phone
10
Associate Director OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is ImaginAb?

ImaginAb's mission is to transform the clinical management of cancer and autoimmune diseases via targeted molecular imaging. We re-engineer therapeutic antibodies against biologically important targets into small proteins optimized for diagnostic imaging with Positron Emission Tomography (PET). We believe that in the era of targeted molecular therapy, there is a major unmet need for true companion in vivo diagnostics to help realize the promise of personalized medicine.

keywords:N/A

N/A

Total Funding

34

Number of Employees

$5.3M

Revenue (est)

-26%

Employee Growth %

N/A

Valuation

N/A

Accelerator

ImaginAb News

2022-04-06 - Automated Accounts Payable Gives Biotech Company New ...

Biotech company ImaginAB -- which develops next-generation cancer-fighting technology -- says it cut down some 1,750 manhours when the...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.5M340%N/A
#2
$3.9M340%N/A
#3
$4.3M373%N/A
#4
$5.4M395%N/A
#5
$9.8M40-7%N/A